Professional Documents
Culture Documents
Perkembangan FE Di UMP
Perkembangan FE Di UMP
Perkembangan FE Di UMP
Current Position:
• Health Economic Working Group, Indonesian Technical Advisory Group on Immunization
(ITAGI), Ministry of Health, Indonesia
• Expert Team, National Committee on National Formulary Development, Ministry of Health,
Indonesia
• Dean, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto
• 2017
– HITAP (+UGM) → modeling Bevacizumab
– Balitbangkes → modeling FE Kanker Serviks
• 2018
– Global Alliance on Vaccine and Immunization
(GAVI) → Costing HPV Vaccine (Jogja)
– Clinton Health Access Initiative (CHAI) →
Policy Recommendation on HPV Vaccine
• 2019
– KPTK → HTA untuk Alteplase
– WHO Geneva → Costing HPV vaccine (Indonesia)
• 2020
– Newton Fund → Ensilication DTP vaccine
– Nederland Leprosy Relief (NLR) → Costing PEP
• 2021
– Cancer Research UK → the viability of a policy and advocacy
research programme on HPV vaccination
• 2022
– Dexa Medica (DLBS) → FE Fitofarmaka
– Ristek BRIN → HPV Vaccine for Head and Neck Cancer
• 2023 on going
– CHAI → Single dose HPV vaccine
– KPTK → HTA Abiraterone for Metastatic Prostate Cancer
– Biofarma → HTA of Biocolomelt for Colorectal Prevention*
• Education
– Integrasi Farmakoekonomi di program studi S1 dan Apoteker
– Farmakoekonomi menjadi penciri di Program Studi S2 Farmasi UMP
• Workshop
– Systematic Review and Meta-Analysis
– Farmakoekonomi Modeling
– Scientific Writing